DERM · NASDAQ
Journey Medical (DERM) Stock Price & Fundamentals
Journey Medical (DERM) closed at $556.37 on Oct 9, 2026, down 1.02% from the previous close of $562.13.
Share price, past year
1Y +3.95%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $556.37 |
| Sep 30, 2026 | $561.41 |
| Aug 31, 2026 | $555.31 |
| Jul 31, 2026 | $594.88 |
| Jun 30, 2026 | $587.45 |
| May 29, 2026 | $609.45 |
| Apr 30, 2026 | $625.85 |
| Mar 31, 2026 | $554.83 |
| Feb 27, 2026 | $581.99 |
| Jan 30, 2026 | $574.93 |
| Dec 31, 2025 | $541.68 |
| Nov 28, 2025 | $551.07 |
| Oct 31, 2025 | $529.73 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- −$0.22
- Revenue (TTM)
- $68.18M
- Net income (TTM)
- −$6.10M
- Shares outstanding
- 11.6M
- Dividend yield
- —
- 52-week range
- $524.92 – $631.20
Financials
Journey Medical reported revenue of $61.86M for fiscal 2025, up 10.20% from fiscal 2024.
Journey Medical reported a net loss of $11.43M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $61.86M | +10.2% | −$11.43M | −18.5% | −$0.47 | — |
| FY2024ended Dec 31, 2024 | $56.13M | −29.1% | −$14.67M | −26.1% | −$0.72 | — |
| FY2023ended Dec 31, 2023 | $79.18M | +7.5% | −$3.85M | −4.9% | −$0.21 | — |
| FY2022ended Dec 31, 2022 | $73.67M | +16.7% | −$29.63M | −40.2% | −$1.69 | — |
| FY2021ended Dec 31, 2021 | $63.13M | +41.8% | −$43.99M | −69.7% | −$4.32 | — |
| FY2020ended Dec 31, 2020 | $44.53M | — | $5.28M | 11.9% | $0.49 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $18.51M | −$312.00K | −$0.01 |
| Q1 FY2026ended Mar 31, 2026 | $15.96M | −$2.23M | −$0.08 |
| Q4 FY2025ended Dec 31, 2025 | $16.08M | −$1.25M | −$0.04 |
| Q3 FY2025ended Sep 30, 2025 | $17.63M | −$2.32M | −$0.09 |
| Q2 FY2025ended Jun 30, 2025 | $15.01M | −$3.80M | −$0.16 |
| Q1 FY2025ended Mar 31, 2025 | $13.14M | −$4.07M | −$0.18 |
| Q4 FY2024ended Dec 31, 2024 | $13.62M | $1.52M | $0.10 |
| Q3 FY2024ended Sep 30, 2024 | $14.63M | −$2.39M | −$0.12 |
Company profile
- Name
- Journey Medical Corp
- Ticker
- DERM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 9237 E Via De Ventura Blvd., Suite 105, Scottsdale, AZ 85258
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001867066
Recent SEC filings
- Aug 12, 2026
- Aug 12, 2026
- Jun 26, 2026
- May 13, 2026
- May 13, 2026
- Apr 21, 2026
- Mar 26, 2026
- Mar 25, 2026
Frequently asked questions
What is Journey Medical's stock price?
Journey Medical (DERM) closed at $556.37 on Oct 9, 2026, down 1.02% from the previous close of $562.13.
How much revenue does Journey Medical make?
Journey Medical reported revenue of $61.86M for fiscal 2025, up 10.20% from fiscal 2024.
Does Journey Medical pay a dividend?
Journey Medical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Journey Medical Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures